Following End-of-Phase 2 meeting, MBX remains on track to initiate Phase 3 in Q3 2026CARMEL, Ind., March 09, 2026 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage ...

Phase 3 trial of once-weekly canvuparatide remains on track to initiate in Q3 2026 following recently completed, successful End-of-Phase 2 meeting with FDA 12-week MAD Phase 1 data from MBX 4291 for ...

Chemical factories power global industry through advanced production, strict compliance, quality control, and digital trade integration, ensuring safe and reliable supply chains. The modern industrial ...

Medication can significantly improve the ability to initiate tasks, sustain attention, and complete responsibilities”— ...

Americas Gold And Silver Announces Largest Ever Exploration Program In 2026 Following The Discovery Of Ten New High-Grade Silver-Copper-Antimony And Silver-Lead Veins At Galena Including 4,896 G/T ...

A home blood pressure telemonitoring (HBPT) program effectively reduced BP in real-world clinical settings, but its enrollment expenses increased overall costs. The HBPT program reduced BP clinic ...